LeonaBio (LONA) Other Non-Current Assets (2020 - 2026)
LeonaBio's (LONA) quarterly Other Non-Current Assets came in at $55000.0 in Q1 2026, down 35.29% year-on-year from $85000.0 in Q1 2025, and little changed on a QoQ basis from $55000.0 in Q4 2025.
LeonaBio (LONA) Other Non-Current Assets (2020 - 2026) Analysis & Trends
LeonaBio (LONA) has 7 years of Other Non-Current Assets data on file, last reported at $55000.0 in Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 35.29% year-over-year to $55000.0 in Q1 2026; TTM through Mar 2026 was $55000.0, a 35.29% decrease from a year earlier, with the FY2025 full-year figure at $55000.0, changed 0.0% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $55000.0, roughly flat from $55000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for LONA reached as high as $631000.0 in Q3 2023 and fell as low as $55000.0 in Q3 2022.
- Historically, Other Non-Current Assets has averaged $178411.8 across 5 years, with a median of $61000.0 in 2023.
- Across the five-year window, Other Non-Current Assets jumped 1047.27% in 2023 and tumbled 91.28% in 2024, its largest moves.
- Year by year, Other Non-Current Assets stood at $55000.0 in 2022, then soared by 1047.27% to $631000.0 in 2023, then tumbled by 91.28% to $55000.0 in 2024, then changed by 0.0% to $55000.0 in 2025, then changed by 0.0% to $55000.0 in 2026.
- Per Business Quant data, the three most recent Other Non-Current Assets figures were $55000.0 in Q1 2026, $55000.0 in Q4 2025, and $55000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 60,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 104.24 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 14.48 Mn |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | 55,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 62,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 55,000.00 |
| Jun 30, 2024 | 55,000.00 |
| Mar 31, 2024 | 631,000.00 |
| Dec 31, 2023 | 631,000.00 |
| Sep 30, 2023 | 631,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | 72,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 55,000.00 |
| Jun 30, 2022 | 210,000.00 |
| Mar 31, 2022 | 210,000.00 |
| Dec 31, 2021 | 56,000.00 |
| Sep 30, 2021 | 125,000.00 |
| Jun 30, 2021 | 225,000.00 |